We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Sector movers: Big Pharma, Aerospace pace gains

Mon 19 February 2024 23:37 | A A A

No recommendation

No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.

(Sharecast News) - UK stocks outperformed those on the Continent for a fourth session in a row in calm trading due to the Presidents' Day holiday Stateside.

Big Pharma paced gains after the US Food and Drug Administration (FDA) granted approval for a combination of its cancer drug Tagrisso with chemotherapy to treat a type of lung cancer.

Aerospace also fared well as investors bid shares of BAE Systems and Rolls-Royce higher ahead of their full-year numbers which were due out on Wednesday and Thursday, respectively.

Shares of industrial miners meanwhile dragged on the FTSE 350 following what some market commentary labelled a "tepid" start of mainland Chinese shares after the Lunar New Year holidays.

Indeed, there was speculation that state funds had stepped in to bolster China's stock markets.

Top performing sectors so far today

Pharmaceuticals & Biotechnology 20,830.23 +1.84%

Leisure Goods 24,145.49 +1.60%

Aerospace and Defence 9,603.40 +1.59%

Telecommunications Service Providers 1,764.03 +1.52%

Construction & Materials 9,378.70 +0.64%

Bottom performing sectors so far today

Tobacco 26,960.75 -1.43%

Non-life Insurance 3,311.48 -1.33%

Industrial Metals & Mining 6,104.77 -1.32%

Automobiles & Parts 1,342.85 -1.10%

Chemicals 9,372.14 -1.09%

    The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.